Plasma and sputum erythromycin concentrations in chronic bronchitis.
AUTOR(ES)
Marlin, G E
RESUMO
Plasma and sputum concentrations of erythromycin were measured in 10 patients with chronic bronchitis during an eight-day course of a new formulation of erythromycin stearate. The plasma erythromycin levels compared favourably with the minimal inhibitory concentrations for common respiratory pathogens and indicated adequate gastrointestinal absorption when the drug was taken immediately before food. Sputum erythromycin levels were variable and in some patients low or undetectable. Measurable sputum erythromycin levels were approximately 10% of plasma levels with no evidence of accumulation and were of similar order of magnitude to the minimal inhibitory concentrations for common respiratory pathogens except Haemophilus influenzae. There was no correlation between sputum and plasma erythromycin levels. There was a trend for higher erythromycin levels in sputum containing increasing amounts of pus and also when plasma levels increased.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=471307Documentos Relacionados
- A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis.
- Cellular characteristics of sputum from patients with asthma and chronic bronchitis.
- Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis.
- Plasma levels of carcinoembryonic antigen in bronchial carcinoma and chronic bronchitis.
- Bronchography in chronic bronchitis.
